“Clinical validity of medial temporal atrophy as a biomarker for Alzheimer’s disease in the context of a structured 5-phase development framework” has been published in the journal Neurobiology of Aging. This work was supported in part by JPND through the BIOMARKAPD project, selected in the 2011 Biomarkers call.

30 Μαρτίου, 2017